GPCR VideoCast << Back to VideoCast list Chris Langmead Chris Langmead is Professor, Deputy Director, Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience Christopher Langmead on the web Monash University T witter Google Scholar Linkedin PubMed Monash Neuromedicines

Arthur Christopoulos Chris Langmead is Professor, Deputy Director, and Better Medicines Theme Leader Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience Christopher Langmead on the web Monash University T witter Google Scholar Linkedin PubMed Monash Neuromedicines

Chris Langmead , Professor and Deputy Director, Neuromedicines Discovery Centre at Monash University

Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

Chris Evans at UCLA.

Chris Evans at UCLA.

Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

provide useful information in relation to receptor-G protein signal transduction. " Authors Xudong Wang , Chris

Chris de Graaf September 14, 2021 at 12:00:00 PM Learn More >> Designer G protein-coupled receptors as

type III secretion apparatus protein), Complex 2 (Protein kinase domain-containing protein-Chemotaxis CheY protein), and Complex 3 (GPCR-Chemotaxis CheY protein) was found to interact with -4319.76, -5271.39

Chris Tate , and Dr. David Gloriam .

INV-202, an Oral, Peripherally-acting CB1 Inverse Agonist, in Patients with Diabetic Kidney Disease Chris